Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
79.73 USD | +0.38% | +1.79% | +0.90% |
Financials (USD)
Sales 2024 * | 371B | Sales 2025 * | 392B | Capitalization | 99.96B |
---|---|---|---|---|---|
Net income 2024 * | 8.81B | Net income 2025 * | 9.86B | EV / Sales 2024 * | 0.4 x |
Net Debt 2024 * | 47.89B | Net Debt 2025 * | 43.21B | EV / Sales 2025 * | 0.37 x |
P/E ratio 2024 * |
11.6
x | P/E ratio 2025 * |
10.2
x | Employees | 259,500 |
Yield 2024 * |
3.33% | Yield 2025 * |
3.54% | Free-Float | 72.24% |
Latest transcript on CVS Health Corporation
1 day | +0.12% | ||
1 week | +0.57% | ||
Current month | +6.80% | ||
1 month | +4.14% | ||
3 months | +0.77% | ||
6 months | +13.83% | ||
Current year | +0.60% |
Managers | Title | Age | Since |
---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
David Falkowski
CMP | Compliance Officer | - | 11-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 18 M€ | +7.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 79.7 | +0.34% | 4 185 916 |
24-03-27 | 79.43 | +0.14% | 10,263,568 |
24-03-26 | 79.32 | +0.43% | 10,158,917 |
24-03-25 | 78.98 | +0.64% | 7,956,840 |
24-03-22 | 78.48 | +0.27% | 11,110,471 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.60% | 99.96B | |
+22.54% | 87.73B | |
+10.63% | 29.33B | |
-4.72% | 18.21B | |
-4.95% | 14.51B | |
+19.29% | 12.22B | |
+30.63% | 12B | |
-1.25% | 11.94B | |
-32.28% | 11.56B | |
-10.67% | 11.63B |